In this context, it seems particularly relevant to assess how tPA plasma levels are affected by normal aging and AD and how they relate to these relevant factors (memory problems, inflammation, amyloid deposition, neurodegeneration and cardiovascular diseases) in normal and pathological aging. The gene discussed is PLAT; the disease is Alzheimer disease.